Perspective: Medical-device startups weather broader market storms
[NOTE: This is a life-sciences perspective piece by Robin Bellas, a partner at Morgenthaler Ventures. For previous perspective pieces, see here. --D.P.H.]
By ROBIN BELLAS
Does an ebb tide lower all boats? Not when the ship you’re sailing was christened “Medical Devices.” Since the beginning of the year, the Dow Jones Medical Equipment Index of public medtech companies has registered a 13 percent increase in value compared to just a 1.6 percent increase for the Standard & Poor… Continue Reading
Perspective: Personalizing Medicine in the Age of Health 2.0
[NOTE: This is a life-science perspective piece by Vance Vanier, a Stanford physician and a partner at Mohr Davidow Ventures. For previous perspective pieces, click here. --D.P.H.]
By VANCE VANIER
Katherine is a 35 year old experiencing fatigue, tingling in her hands, and visual problems. She made an appointment with her doctor, arrived with a stack of online health site print-outs, and announced that she had diagnosed her problem as a relatively rare pituitary tumor. She was… Continue Reading
Perspective: Patents, post-MedImmune
[NOTE: This article inaugurates our “Perspective” feature, in which entrepreneurs, investors, and other experts discuss developments or pressing issues within the life sciences -- a parallel effort to the "Contributors" section on the main VentureBeat page. We ultimately hope to distinguish perspective pieces from our regular coverage with a distinctive font and other visual elements, but for now, they'll just be labeled clearly and will carry a note much like this one. --D.P.H.]
By SERGIO GARCIA… Continue Reading